Dr. Fish joined our Board of Directors in January 2022.  With over 30 years of experience in health care, life sciences, and biotechnology, Dr. Fish has a particular interest in cost-reducing strategies utilizing value-based reimbursement models. Dr. Fish is currently the CEO of the Greater Lawrence Family Health Centers, a nationally recognized Federally Qualified Health Center operating 9 clinical sites serving 70,000 patients. 

Previously, Dr. Fish was CEO of Cellanyx, a cancer diagnostic company saving patients unnecessary surgery and complications by differentiating aggressive from indolent tumors. He has also worked as VP of Business Development at International Collagenesis, a tissue-engineering firm, as a securities analyst in the medical devices sector for Sanford Bernstein, as a healthcare consultant at The Boston Consulting Group, and as a solo practice physician. Dr. Fish is a Trustee Advisor of Beth Israel Deaconess Medical Center in Boston, where he previously chaired the Patient Care Committee and holds membership on the Patient Care Assessment and Quality Committee, and Medical Education Committee. He has served as Chairman of the Licensing Board for Dubai Health Care, as well as the Licensing Committee for the Board of Registration in Medicine for the Commonwealth of Massachusetts. Dr. Fish is currently a member of the Board of Directors of Etiometry and of the Altarum Institute. 

Dr. Fish is Board Certified in Internal Medicine, holds an MBA from the Yale School of Management, an MD from the Yale School of Medicine, and a bachelor's degree in biochemistry from Harvard University. 

Dr. Fish is a medical doctor with substantial capital markets experience.  We believe his leadership endeavors as an investor, board member, and/or senior executive of numerous innovative medical device companies and other healthcare organizations, enable him to add perspective and value as a member of the board.